|
|
|
|
pmid:
|
Weintraub NL et al. |
Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids. |
1999 |
Am. J. Physiol. |
pmid:10564166
|
Tréluyer JM et al. |
Ontogenesis of CYP2C-dependent arachidonic acid metabolism in the human liver: relationship with sudden infant death syndrome. |
2000 |
Pediatr. Res. |
pmid:10813596
|
Campbell WB et al. |
14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels. |
2002 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:11959628
|
Oleksiak MF et al. |
Identification and regulation of a new vertebrate cytochrome P450 subfamily, the CYP2Ps, and functional characterization of CYP2P3, a conserved arachidonic acid epoxygenase/19-hydroxylase. |
2003 |
Arch. Biochem. Biophys. |
pmid:12623071
|
Widstrom RL et al. |
Fatty acid-binding proteins inhibit hydration of epoxyeicosatrienoic acids by soluble epoxide hydrolase. |
2003 |
Biochemistry |
pmid:14529287
|
Krötz F et al. |
Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids. |
2004 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:14715644
|
Roy U et al. |
Cytochrome P450/NADPH-dependent formation of trans epoxides from trans-arachidonic acids. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:15013014
|
Fang X et al. |
Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels. |
2004 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15284062
|
Nithipatikom K et al. |
Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway. |
2004 |
Circ. Res. |
pmid:15388642
|
Spiecker M et al. |
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. |
2004 |
Circulation |
pmid:15466638
|
Gauthier KM et al. |
Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15528233
|
Fang X et al. |
14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha. |
2006 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:16113065
|
Ng VY et al. |
Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha. |
2007 |
Drug Metab. Dispos. |
pmid:17431031
|
Ghosh S et al. |
Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats. |
2008 |
Basic Clin. Pharmacol. Toxicol. |
pmid:18312493
|
Zhang W et al. |
Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia. |
2009 |
J. Cereb. Blood Flow Metab. |
pmid:19471280
|
Shen HC et al. |
Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors. |
2009 |
Bioorg. Med. Chem. Lett. |
pmid:19682899
|
Liu JY et al. |
Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. |
2010 |
Biochem. Pharmacol. |
pmid:19896470
|
Xu X et al. |
Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice. |
2010 |
Diabetes |
pmid:20068141
|
Zheng C et al. |
Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats. |
2010 |
Am. J. Respir. Cell Mol. Biol. |
pmid:20118222
|